Teva Pharmaceuticals USA has launched the first generic version of Azopt in the United States.
The generic version of Azopt (brinzolamide ophthalmic suspension) 1% offers another treatment option for patients with ocular hypertension or open-angle glaucoma to lower elevated pressure in the eye by decreasing fluid, according to a press release.
“Continuing to pursue much-needed generic drugs is critical to ensuring access to quality medicines to everyone who needs them,” Christine Baeder, senior vice president, chief operating officer of US Generics, Teva USA, said in the release.
Uncategorized